Alphabiome AI
AI-Powered Microbiome Intelligence for Human Health
Company Overview
Snapshot
Founded in March 2022 by Yaniv Altshuler, Alphabiome AI operates with 1–10 employees. The company has raised $8,000,000 across four funding rounds from three investors. In May 2025, Alphabiome AI secured seed funding, with.
Business overview
Alphabiome AI leverages artificial intelligence to analyze the genetic complexities of the human microbiome, aiming to identify biomarkers that predict treatment efficacy. The company's proprietary technology facilitates large-scale, reference-free analysis of microbial DNA, converting genetic data into actionable insights for drug development, clinical decision-making, and precision medicine. Alphabiome AI operates within the Health Tech & Life Sciences sector, focusing on healthcare, biotechnology, and personalized medicine markets.
Strategic signal
In May 2025, Alphabiome AI successfully raised $8 million in seed funding. This capital infusion, with AIX Ventures as a lead investor, signals strong investor confidence in the company's AI-powered microbiome intelligence platform and its potential to transform disease understanding, diagnosis, and treatment. The funding is expected to accelerate the development and commercialization of its technology, positioning Alphabiome AI for significant growth in the precision medicine and drug development sectors.
Log in to access full profile ›Company Intelligence Q&A
- What is Alphabiome AI's core mission?
- Alphabiome AI's mission is to unlock the full potential of the human microbiome to transform how diseases are understood, diagnosed, and treated by using artificial intelligence to decode genetic complexity and identify predictive biomarkers.
- When was Alphabiome AI founded?
- Alphabiome AI was founded in March 2022.
- What was Alphabiome AI's most recent funding event?
- In May 2025, Alphabiome AI raised $8,000,000 in seed funding. AIX Ventures participated as a lead investor in this round.
- Which investor participated in Alphabiome AI's July 2024 funding round?
- In July 2024, iSelect Fund participated in a seed funding round for Alphabiome AI.
- Which investor has made multiple investments in Alphabiome AI?
- New Era Capital Partners has made multiple investments in Alphabiome AI, including a SAFE round in April 2024 and a convertible debt round in June 2022.